Karydas Daphne bought MLYS

November 13, 2025 · Form 4 insider transaction

Karydas Daphne bought 15,000 shares of Mineralys Therapeutics, Inc. at $10.20 per share, a transaction worth $153.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.